Tirzepatide is taken in a once-weekly injection
That is the test before you invest approach genetic context first, then an informed conversation with your provider
Glucagon-like peptide-1 receptor (GLP-1) agonists are an effective treatment for controlling blood glucose levels in people with type 2 diabetes, particularly those who do not respond, or stop responding to, first-line treatments, such as There are many versions of GLP-1 drugs, including: liraglutide(Victoza), which people inject daily semaglutide (Rybelsus), an oral tablet which people take once daily dulaglutide(Trulicity), which people inject once a week semaglutide (Ozempic/ Wegovy), which people inject once a week exenatide(Bydureon), which people inject once a week
Normally, if an overweight person loses a substantial amount of weight, we expect to see improvements in their aerobic fitness (relative to body mass) and cardiovascular health
If you need help discussing GLP-1 with others, our guide on what to say when requesting GLP-1 options offers practical conversation templates
The 2024 average first-time AOM semaglutide prescription rate was 17.7-fold higher than the first-time AOM liraglutide prescription rate